Explore the vast range of titles available.

Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents-their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank.

[This corrects the article DOI: 10.1371/journal.pone.0272826.].

Since the Industrial Revolution, atmospheric CO2 concentrations have increased by c. 50%, from 280 ppm to a current level of 415 ppm and rising (Ciais et al., 2013). But CO2 concentrations would be even higher if the terrestrial biosphere was not acting as a carbon sink, absorbing c. 30% of the CO2 we emit every year (Le Quéré et al., 2016). Understanding how increasing CO2 concentrations will alter the ability of vegetation and soils to sequester carbon is therefore critical for predicting the trajectory of future climate change, since a reduction in this carbon sink would cause a more rapid accumulation of CO2 in the atmosphere (Dusenge et al., 2019). In this issue of New Phytologist, Walker et al. (2021; pp. 2413–2445) synthesize data from an incredibly broad range of sources, including herbaria, free air CO2 enrichment (FACE) studies, ice cores, eddy covariance sites, and remote sensing, and examine an enormous diversity of measurements (such as soil respiration rates, glucose isotopomers from leaves, tree ring width data, stream-gauges for runoff, and direct atmospheric CO2 measurements) to address the question of how increasing CO2 concentrations are affecting the carbon uptake capacity of our planet.

Background The overuse of antibiotics has led to increased antimicrobial resistance, but plant-derived biological response modifiers represent a potential alternative to these drugs. This investigation examined the immunomodulatory and antibacterial activities of Sida cordifolia (used in ethnomedicinal systems to treat infectious disease). Methods Successive extractions were performed from the roots of these plants in hexane, chloroform, methanol and water. Immunomodulatory activity was determined in a series of experiments measuring the responses of splenocytes, macrophages and an in vivo model of innate immunity ( Galleria mellonella ) . Antibacterial activity was assessed by determining minimum inhibitory/bactericidal concentrations (MIC/MBCs) for various Gram-positive and Gram-negative bacterial strains. Results Immunomodulatory activity was confined to the aqueous extract, and further fractionation and biochemical analysis yielded a highly potent polysaccharide-enriched fraction (SCAF5). SCAF5 is a complex mixture of different polysaccharides with multiple immunomodulatory effects including immune cell proliferation, antibody secretion, phagocytosis, nitric oxide production, and increased expression of pro-inflammatory cytokines. Furthermore, Galleria mellonella pre-treated with SCAF5 produced more haemocytes and were more resistant ( P  < 0.001) to infection with methicillin-resistant Staphylococcus aureus (MRSA) with a 98% reduction in bacterial load in pre-treated larvae compared to the negative control. The antibacterial activity of Sida cordifolia was confined to the methanolic fraction. Extensive fractionation identified two compounds, rosmarinic acid and its 4-O-β-d-glucoside derivative, which had potent activity against Gram-positive antibiotic-resistant bacteria, including MRSA. Conclusions Sida cordifolia counters bacterial infections through a dual mechanism, and immunomodulatory polysaccharides from this plant should be isolated and characterised to realise their potential as anti-infective agents. Such properties could be developed as an antibiotic alternative (1) in the clinic and (2) alternative growth promoter for the agri-food industry.